APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

BACKGROUND: The APOE genotype predicts the age at onset of Alzheimer disease (AD) and neuropathologic progression. However, studies relating APOE alleles to the rate of cognitive decline have been inconclusive. This may stem from their use of linear statistical analyses. OBJECTIVE: To model relation...

Full description

Bibliographic Details
Main Authors:	Martins, C, Oulhaj, A, de Jager, C, Williams, J
Format:	Journal article
Language:	English
Published:	2005

Similar Items

Homocysteine as a predictor of cognitive decline in Alzheimer's disease.
by: Oulhaj, A, et al.
Published: (2010)

Homocysteine as a predictor of cognitive decline in Alzheimer's disease
by: Oulhaj, A, et al.
Published: (2010)

APOE epsilon 4 allele affects presynaptic, but not postsynaptic cholinergic markers in Alzheimer's disease neocortex
by: Lai, M, et al.
Published: (2006)

Selective effects of the APOE epsilon4 allele on presynaptic cholinergic markers in the neocortex of Alzheimer's disease.
by: Lai, M, et al.
Published: (2006)

Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease
by: Allen, G, et al.
Published: (2016)

Postmortem serotoninergic correlates of cognitive decline in Alzheimer's disease.
by: Lai, M, et al.
Published: (2002)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
by: Holmes, C, et al.
Published: (2005)

APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review
by: O'Donoghue, M, et al.
Published: (2018)

Predicting cognitive decline in healthy older adults.
by: De Jager, C, et al.
Published: (2005)

PSEN1 polymorphisms alter the rate of cognitive decline in sporadic Alzheimer's disease patients.
by: Belbin, O, et al.
Published: (2009)

The -491A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEepsilon4 allele and Alzheimer's disease.
by: Ahmed, A, et al.
Published: (1999)

Genetic risk and resilience for Alzheimer’s disease: The effect of the three APOE alleles on brain function across life
by: Suri, S
Published: (2016)

Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment
by: Oulhaj, A, et al.
Published: (2016)

Levels of CSF prostaglandin E2, cognitive decline, and survival in Alzheimer's disease.
by: Combrinck, M, et al.
Published: (2006)

New role for ApoE in the pathogenesis of Alzheimer's disease?
by: Nagy, Z, et al.
Published: (2000)

Rate of brain aging and APOE ε4 are synergistic risk factors for Alzheimer’s disease
by: Glorioso, Christin A, et al.
Published: (2021)

Rate of brain aging and APOE ε4 are synergistic risk factors for Alzheimer’s disease
by: Glorioso, Christin A., et al.
Published: (2022)

Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene and the rate of cognitive decline in Alzheimer's disease.
by: Belbin, O, et al.
Published: (2007)

Association of the APOE epsilon4 allele with disease activity in multiple sclerosis.
by: Evangelou, N, et al.
Published: (1999)

Microanatomical correlates of cognitive ability and decline: normal ageing, MCI, and Alzheimer's disease.
by: Chance, SA, et al.
Published: (2011)

Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.
by: Lai, M, et al.
Published: (2005)

Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer's disease.
by: De Jager, C, et al.
Published: (2003)

Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial.
by: Ballard, C, et al.
Published: (2005)

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
by: Ballard, C, et al.
Published: (1996)

The forgotten APOE allele: a review of the evidence and suggested mechanisms for the protective effect of APOE ɛ2.
by: Suri, S, et al.
Published: (2013)

The forgotten APOE allele: A review of the evidence and suggested mechanisms for the protective effect of APOE e2
by: Suri, S, et al.
Published: (2013)

Constructional apraxia in Alzheimer's disease: association with occipital lobe pathology and accelerated cognitive decline.
by: Smith, M, et al.
Published: (2001)

Building in vitro models of the brain to understand the role of APOE in Alzheimer’s disease
by: Pinals, Rebecca L, et al.
Published: (2023)

The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease.
by: Trachtenberg, A, et al.
Published: (2012)

The effects of APOE on brain activity do not simply reflect the risk of Alzheimer's disease
by: Trachtenberg, A, et al.
Published: (2012)

Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE‐ε4/TOMM40 long poly‐T repeat allele variants
by: Prokopenko, I, et al.
Published: (2019)

Role of depression in predicting time to conversion to mild cognitive impairment
by: Dean, K, et al.
Published: (2014)

Role of depression in predicting time to conversion to mild cognitive impairment.
by: Dean, K, et al.
Published: (2014)

Changes over time in memory, processing speed and clock drawing tests help to discriminate between vascular cognitive impairment, mild cognitive impairment and Alzheimer's disease.
by: de Jager, C
Published: (2004)

Psychotic symptoms in dementia and the rate of cognitive decline.
by: Ballard, C, et al.
Published: (1997)

Computerized adaptation of the Placing Test for early detection of both mild cognitive impairment and Alzheimers disease
by: Vacante, M, et al.
Published: (2013)

Computerized adaptation of The Placing Test for early detection of both mild cognitive impairment and Alzheimer's disease.
by: Vacante, M, et al.
Published: (2013)

The effects of cell cycle progression and Alzheimer-type pathology on cognitive decline
by: Smith, M, et al.
Published: (2000)

Loss of serotonin 5-HT2A receptors in, the temporal cortex correlates with cognitive decline in Alzheimer's disease
by: Lai, K, et al.
Published: (2004)

THE ROLE OF DEPRESSION IN PREDICTING THE TIME TO DEVELOPMENT OF MILD COGNITIVE IMPAIRMENT: A COHORT STUDY
by: Dean, K, et al.
Published: (2012)